National Cancer Institute Funds Second Year of Grant to Guided Therapeutics, Inc. to Commercialize Non-invasive Cervical Cancer Detection Device
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (GT) (OTCBB: GTHP) today announced that it was awarded $1.0 million to fund the second year of a $2.5 million grant from the National Cancer Institute (NCI) announced in 2009.